Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrp Advisory Group Regulatory News (FRP)

Share Price Information for Frp Advisory Group (FRP)

Share Price is delayed by 15 minutes
Get Live Data
117.00    4.00 (3.54%)
Bid:
116.00
Ask:
118.00
Spread: 2.00 (1.724%)
Market Cap: £289.10m
FRP Live PriceLast checked at - London Stock Exchange

Intraday Frp Advisory Group Share Chart

Director/PDMR Shareholding

14 May 2009 08:57

RNS Number : 2373S
Fairpoint Group PLC
14 May 2009
 



FAIRPOINT PLC

11 May 2009

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

This form is intended for use by an issuer to make a RIS notification required

by DR 3.1.4R(1).

(1) An issuer making a notification in respect of a transaction relating to the

shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2) An issuer making a notification in respect of a derivative relating to the

shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3) An issuer making a notification in respect of options granted to a director/

person discharging managerial responsibilities should complete boxes 1 to 3 and

17 to 24.

(4) An issuer making a notification in respect of a financial instrument

relating to the shares of the issuer (other than a debenture) should complete

boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

Please complete all relevant boxes in block capital letters.

1. Name of the issuer

FAIRPOINT PLC

2. State whether the notification relates to

(i) a transaction notified in accordance with DR 3.1.4R(1)(a); or

(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or

(iii) both (i) and (ii)

(i) A TRANSACTION NOTIFIED IN ACCORDANCE WITH DR3.1.4R(1)(a)

3. Name of person discharging managerial responsibilities/director

MATTHEW PEACOCK 

4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

Connected person: DAUPHIN CAPITAL LLC

5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

THE NOTIFICATION RELATES TO THE PERSON REFERRED TO IN 4 ABOVE

6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares

1P ORDINARY SHARES

7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

VIDACOS NOMINEES LIMITED - 9,730,635 SHARES ON BEHALF OF HANOVER MASTER FUND LP

HANOVER INVESTORS MANAGEMENT (CAYMAN) LTD - 180,000

DAUPHIN CAPITAL LLC - 232,825  after current purchase

8 State the nature of the transaction

PURCHASE OF SHARES

9. Number of shares, debentures or financial instruments relating to shares acquired

80,000 On 6 May 2009

10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

0.54%

11. Number of shares, debentures or financial instruments relating to shares disposed

N/A

12. Percentage of issued class disposed (treasury shares of that class should

not be taken into account when calculating percentage)

N/A

13. Price per share or value of transaction

80,000 SHARES PURCHASED AT 61p

14. Date and place of transaction

6 May 2009LONDON

15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when

calculating percentage)

VIDACOS NOMINEES LIMITED - 9,730,635 SHARES ON BEHALF OF HANOVER MASTER FUND LP - 22.70%

HANOVER INVESTORS MANAGEMENT (CAYMAN) LTD - 180,000 - 0.42%

DAUPHIN CAPITAL LLC - 232,825 - 0.54%

16. Date issuer informed of transaction

11 May 2009

If a person discharging managerial responsibilities has been granted options by

the issuer complete the following boxes

17. Date of grant

N/A

18. Period during which or date on which it can be exercised

N/A

19. Total amount paid (if any) for grant of the option

N/A

20. Description of shares or debentures involved (class and number)

N/A

21. Exercise price (if fixed at time of grant) or indication that price is to be

fixed at the time of exercise

N/A

22. Total number of shares or debentures over which options held following

notification

N/A

23. Any additional information

N/A

24. Name of contact and telephone number for queries

Michael Smith 0207 766 8408

Name and signature of duly authorised officer of issuer responsible for making

Notification

Date of notification

11 May 2009


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSDZLBFKEBEBBE
Date   Source Headline
21st May 20264:39 pmRNSHolding(s) in Company
21st May 20264:22 pmRNSPurchase of Ordinary Shares by EBT
15th May 20267:00 amRNSFull Year Trading Update
27th Apr 20267:00 amRNSShareholder Lock-Ins
20th Mar 202610:43 amRNSHolding(s) in Company
17th Mar 20261:49 pmRNSHolding(s) in Company
27th Feb 20266:15 pmRNSHolding(s) in Company
27th Feb 20266:08 pmRNSHolding(s) in Company
23rd Feb 20267:00 amRNSQ3 Dividend Declaration
13th Jan 20262:51 pmRNSChange of Auditor
9th Jan 20263:40 pmRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSGrant of Options and Director Dealing
19th Dec 20257:00 amRNSGrant of Options and Director Dealing
18th Dec 20257:00 amRNSHalf-year Report
1st Dec 20256:08 pmRNSTotal Voting Rights
21st Nov 20257:00 amRNSTrading Statement
14th Nov 20257:00 amRNSAcquisition of Arc & Co Structured Finance Limited
23rd Sep 20253:43 pmRNSResult of AGM
23rd Sep 20257:00 amRNSAGM Statement and Q1 Dividend Declaration
3rd Sep 20257:00 amRNSDirector/PDMR Shareholding
26th Aug 20255:32 pmRNSNotice of Annual General Meeting
19th Aug 202510:04 amRNSAnnual Financial Report
19th Aug 20258:45 amRNSGrant of Options and Director Dealing
23rd Jul 20257:00 amRNSFull Year Results
30th May 20257:00 amRNSTotal Voting Rights
12th May 20257:00 amRNSAcquisition of One Advisory Group
8th May 20257:00 amRNSFull Year Trading Update
1st May 20253:35 pmRNSAIM Rule 17 Update
11th Mar 20251:55 pmRNSDirector/PDMR Shareholding
17th Feb 20257:00 amRNSQ3 Trading Update and Dividend Declaration
14th Jan 20257:00 amRNSAppointment of Joint Corporate Broker
10th Jan 20255:00 pmRNSDirector/PDMR Shareholding
17th Dec 20247:00 amRNSHalf-year Report
20th Nov 20247:00 amRNSHalf Year Trading Update
31st Oct 20247:00 amRNSTotal Voting Rights
25th Oct 20247:00 amRNSHolding(s) in Company
17th Oct 20247:00 amRNSAcquisition of Globalview Advisors Limited
15th Oct 20242:42 pmRNSPDMR Dealing
30th Sep 202410:22 amRNSTotal Voting Rights
26th Sep 202410:49 amRNSResult of AGM
26th Sep 20247:00 amRNSAGM Statement and Q1 Dividend Declaration
23rd Sep 20247:00 amRNSDirector/PDMR Shareholding
4th Sep 20247:00 amRNSAcquisition of WilliamsAli Corporate Finance
23rd Aug 20247:00 amRNSNotice of AGM
16th Aug 202411:39 amRNSAnnual Report & Accounts
1st Aug 20243:35 pmRNSDirector/PDMR Shareholding
31st Jul 202410:50 amRNSTotal Voting Rights
24th Jul 20242:40 pmRNSReplacement - Full Year Results
24th Jul 20247:00 amRNSFull Year Results
19th Jul 202411:43 amRNSAcquisition of Lexington Corporate Finance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.